3643companies in the directory 1104ISIN verified against the check digit 7exchanges 14sectors No real-time quotes — a reference work, not a trading platform3643companies in the directory 1104ISIN verified against the check digit 7exchanges 14sectors No real-time quotes — a reference work, not a trading platform
DE · EN Newsletter
Biotech & Pharma Symbolbild · KI-generiert
Biotech & Pharma PRGO

Perrigo Company plc

PRGO NYSE IE00BGH1M568 Biotech & Pharma

Stock factsheet

TickerPRGO
ExchangeNYSE
ISINIE00BGH1M568
WKN
SectorBiotech & Pharma
Size class Small Cap
Market capitalisation 1,40 Mrd. USD As of 2026-08-03

Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.

Company profile

Perrigo is an Irish pharmaceutical company specialising in the manufacture and distribution of over-the-counter (OTC) healthcare products and generic medicines. The company supplies retail chains, drugstores and online retailers with own-label products. Perrigo is one of the world's largest manufacturers of store-brand OTC medicines.

Short profile generated automatically and checked for plausibility. A full editorial profile follows once we cover the company.

Share price

Price data from TradingView, possibly delayed. Not investment advice.

Comparable companies

Companies in the Biotech & Pharma sector of a similar size.

CompanyTickerExchangeMarket cap
Perrigo Company plcPRGO NYSE1,40 Mrd. USD
Monte Rosa Therapeutics, Inc. GLUENASDAQ 1,40 Mrd. USD
Xeris Biopharma Holdings, Inc. XERSNASDAQ 1,39 Mrd. USD
ArriVent BioPharma, Inc. AVBPNASDAQ 1,39 Mrd. USD
CONMED Corporation CNMDNYSE 1,39 Mrd. USD
Anbio Biotechnology NNNNNASDAQ 1,42 Mrd. USD
MoonLake Immunotherapeutics MLTXNASDAQ 1,36 Mrd. USD

Investor Relations

Annual reports Not recorded yet
Investor presentation Not recorded yet
Analyst coverage Not recorded yet

We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.

Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.